AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
India · Delayed Price · Currency is INR 8,433.50
-95.50 (-1.12%)
Jun 19, 2026, 3:29 PM IST
AstraZeneca Pharma India Market Cap
AstraZeneca Pharma India has a market cap or net worth of 210.17 billion as of June 18, 2026. Its market cap has increased by 5.54% in one year.
Market Cap
210.17B
Enterprise Value
206.79B
Revenue
22.76B
Ranking
n/a
PE Ratio
112.08
Stock Price
8,433.50
Market Cap Chart
Since February 27, 2002, AstraZeneca Pharma India's market cap has increased from 1.45B to 210.17B, an increase of 14,394.14%. That is a compound annual growth rate of 22.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 210.17B | -6.70% |
| Dec 31, 2025 | 225.25B | 23.26% |
| Dec 31, 2024 | 182.75B | 32.43% |
| Dec 29, 2023 | 138.00B | 67.65% |
| Dec 30, 2022 | 82.31B | 6.20% |
| Dec 31, 2021 | 77.51B | -32.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 393.29B |
| Ajanta Pharma | 384.62B |
| Gland Pharma | 358.95B |
| Emcure Pharmaceuticals | 328.94B |
| Wockhardt | 311.85B |
| Piramal Pharma | 217.33B |
| Eris Lifesciences | 190.74B |
| Cohance Lifesciences | 165.42B |